Targeting exon 20 insertion mutations in lung cancer.
Current opinion in oncology（2023）
摘要
Recent clinical evidence indicates that targeted therapies could improve survival benefits to some extent. More efforts on drug development are underway to bring higher response rates both extracranial and intracranial, sustained clinical remission, and better survival benefits.
更多查看译文
关键词
epidermal growth factor receptor exon 20 insertion,non-small cell lung cancer,novel therapies,tyrosine kinase inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要